BRUCE C HORTEN
Medical Practice at United Nations Plz, New York, NY

License number
Florida 112313
Issued Date
Mar 6, 2012
Effective Date
Mar 4, 2016
Expiration Date
Jan 31, 2018
Category
Health Care
Type
Medical Doctor
Address
Address
845 United Nations Plz APT 77-B, New York, NY 10017
Phone
(917) 697-7904

Professional information

Bruce Carl Horten Photo 1

Bruce Carl Horten, New York NY

Specialties:
Pathologist
Address:
521 W 57Th St, New York, NY 10019
Education:
Duke University, School of Medicine - Doctor of Medicine
UCSF Medical Center - Residency - Clinical Pathology
Stanford Hospital & Clinics - Residency - Neuropathology (Pathology)
New York Presbyterian Hospital/Weill Cornell Medical Center - Residency - Anatomic Pathology
Board certifications:
American Board of Pathology Certification in Anatomic Pathology (Pathology), American Board of Pathology Certification in Clinical Pathology (Pathology), American Board of Pathology Sub-certificate in Neuropathology (Pathology)


Bruce Horten Photo 2

Bruce Horten, New York NY

Work:
Genzyme Genetics
521 W 57Th St, New York, NY 10019


Bruce C Horten Photo 3

Dr. Bruce C Horten, New York NY - MD (Doctor of Medicine)

Specialties:
Neuropathology
Address:
Genzyme Genetics
521 W 57Th St, New York 10019
(212) 698-0300 (Phone)
Certifications:
Anatomic Pathology, 1974, Clinical Pathology, 1982, Neuropathology, 1975
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Genzyme Genetics
521 W 57Th St, New York 10019
Westchester Medical Center
100 Woods Rd, Valhalla 10595
Education:
Medical School
Duke University School Of Medicine
Graduated: 1969
Duke University Hospital
Graduated: 1970
New York Hospital
Graduated: 1974
Stanford University Med Center
Graduated: 1976
University Of California San Francisco
Graduated: 1982


Bruce Horten Photo 4

Methods For Detecting Tumor Origin Based On Muc1, Muc2, And Ck-17 Expression Levels

US Patent:
2011025, Oct 20, 2011
Filed:
Apr 15, 2011
Appl. No.:
13/087908
Inventors:
Bruce Horten - New York NY, US
Thomas Scholl - Westborough MA, US
International Classification:
C12Q 1/68, G01N 33/574, G01N 33/53
US Classification:
435 611, 435 71, 435 723
Abstract:
Methods and compositions for detecting tumor origin are disclosed. In certain embodiments, the origin is determined by detecting expression levels of pan-epithelial membrane mucin (MUC1), intestinal-type secretory mucin (MUC2), cytokeratin 17 (CK17), or a combination thereof. Also disclosed are methods for aiding in the determination of an appropriate course of treatment for a subject with a tumor, or for predicting a therapeutic outcome of a subject, based on the expression levels of MUC1, MUC2, CK17, or a combination thereof. Kits for use in each of these methods are also provided.